Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer
Liu Yang, Fan Li, Feng Gao, et al.
Tumor Biology (2016) Vol. 37, Iss. 11, pp. 15283-15291
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Chemoresistance in Pancreatic Cancer
Siyuan Zeng, Marina Pöttler, Bin Lan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 508
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane, Arielle Rowe, Nicholas Ekow Thomford, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1586-1586
Open Access | Times Cited: 369
Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression
Laura González‐González, Javier Alonso
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 252
The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2
Philipp Neumann, Nicolas Jaé, Andrea Knau, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 181
Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Patricia Dauer, Alice Nomura, Ashok Saluja, et al.
Pancreatology (2016) Vol. 17, Iss. 1, pp. 7-12
Open Access | Times Cited: 131
Targeting Pancreatic Stellate Cells in Cancer
Jonas Schnittert, Ruchi Bansal, Jai Prakash
Trends in cancer (2019) Vol. 5, Iss. 2, pp. 128-142
Open Access | Times Cited: 118
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
Manoj Amrutkar, Monica Aasrum, Caroline S. Verbeke, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 94
Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.
Shunda Wang, Yatong Li, Xing Cheng, et al.
PubMed (2020) Vol. 10, Iss. 7, pp. 1937-1953
Closed Access | Times Cited: 93
Periostin: biology and function in cancer
Shima Dorafshan, Mahdieh Razmi, Sadegh Safaei, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 61
Fibroblasts in pancreatic cancer: molecular and clinical perspectives
Rita Rebelo, Cristina P. R. Xavier, Elisa Giovannetti, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 439-453
Closed Access | Times Cited: 41
Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance
Anastasia N. Kazakova, Maria M. Lukina, Ksenia S. Anufrieva, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
Yang Wu, Chun Zhang, Kuirong Jiang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 54
Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype
Mirna Swayden, Juan Iovanna, Philippe Soubeyran
Heliyon (2018) Vol. 4, Iss. 12, pp. e01055-e01055
Open Access | Times Cited: 57
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27
The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets
Batoul Farran, Ganji Purnachandra Nagaraju
Cytokine & Growth Factor Reviews (2019) Vol. 48, pp. 11-23
Closed Access | Times Cited: 42
MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway
Tingting Wang, Gang Chen, Xuemei Ma, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 3
Open Access | Times Cited: 41
The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets
Prarthana Gopinath, Aparna Natarajan, Amritha Sathyanarayanan, et al.
Gene (2022) Vol. 815, pp. 146137-146137
Closed Access | Times Cited: 22
Pancreatic stellate cells: what's new?
Tony Pang, Jeremy S. Wilson, Minoti V. Apte
Current Opinion in Gastroenterology (2017) Vol. 33, Iss. 5, pp. 366-373
Closed Access | Times Cited: 36
Ping-Pong—Tumor and Host in Pancreatic Cancer Progression
Wei Mu, Zhe Wang, Margot Zöller
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 30
Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies
Maria V. Monteiro, Vítor M. Gaspar, Luís Mendes, et al.
Small Methods (2021) Vol. 5, Iss. 5
Closed Access | Times Cited: 24
Nanomedicine Strategies for Targeting Tumor Stroma
Mei‐Chi Su, Susheel Kumar Nethi, Pavan Kumar Dhanyamraju, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4145-4145
Open Access | Times Cited: 10
BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis
Wei‐Ming Wang, Xiang Zhou, Lingming Kong, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1540-1540
Open Access | Times Cited: 3
Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods
Yi Lü, Chujun Li, Honglei Chen, et al.
Molecular Biology Reports (2018) Vol. 45, Iss. 6, pp. 1799-1807
Closed Access | Times Cited: 28
Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
Sumit Sahni, Christopher B. Nahm, Christoph Krisp, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 26
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
Khine Kyaw Oo, Thanpawee Kamolhan, Anish Soni, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top